
|Articles|July 2, 2017
Orphan Drug Evaluation Overhaul Highlights AJPB Week in Review
Author(s)AJPB staff
Top articles of the week from The American Journal of Pharmacy Benefits.
Advertisement
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Examining the Safety Profiles of SG and Pembrolizumab in ASCENT-04
2
FDA Accepts Furosemide Autoinjector sNDA for Treatment of Edema in Chronic Kidney Disease or Chronic Heart Failure
3
FDA Approves Pirtobrutinib for Relapsed or Refractory Chronic Lymphocytic Leukemia
4
Navigating the New Standard of Care: Patient Needs and the Pharmacist’s Critical Role in Perioperative MIBC Treatment
5


















































































































































































































